Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 10, 2027

Study Completion Date

April 10, 2028

Conditions

Craniopharyngioma

Interventions

DRUG

Oral dabrafenib and trametinib

Neoadjuvant or postoperative treatment of patients with verified BRAF mutated papillary craniopharyngioma

Trial Locations (1)

RECRUITING

Department of Endocrinology, Lund